Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
129M
-
Shares change
-
+2.29M
-
Total reported value, excl. options
-
$1.95B
-
Value change
-
+$10.8M
-
Put/Call ratio
-
1.15
-
Number of buys
-
180
-
Number of sells
-
-203
-
Price
-
$15.10
Significant Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q1 2024
519 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
of 176M outstanding shares and own 73.49% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (17.3M shares), ARK Investment Management LLC (16M shares), BlackRock Inc. (14.2M shares), Sumitomo Mitsui Trust Holdings, Inc. (7.18M shares), Nikko Asset Management Americas, Inc. (7.18M shares), STATE STREET CORP (6.01M shares), RENAISSANCE TECHNOLOGIES LLC (5.53M shares), DIMENSIONAL FUND ADVISORS LP (4.86M shares), FIRST TRUST ADVISORS LP (3.05M shares), and Man Group plc (2.62M shares).
This table shows the top 410 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.